Plans Advance for Biomarkers Panel to Assess Drug-induced Skeletal Muscle Injury - a podcast by SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses plans being advanced for a biomarkers panel to assess drug-induced skeletal muscle injury in SMA.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today